272 related articles for article (PubMed ID: 31810721)
1. D-dimer and C-reactive Protein as Potential Biomarkers for Diagnosis of Trousseau's Syndrome in Patients with Cerebral Embolism.
Tsushima M; Metoki N; Hagii J; Saito S; Shiroto H; Yasujima M; Kato T; Kudo N; Toyama Y; Yokono Y; Nozaka M; Kawamura Y; Nakata M; Tomita H
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104534. PubMed ID: 31810721
[TBL] [Abstract][Full Text] [Related]
2. Features of Patients Aged 80 Years or Older with Embolic Stroke of Undetermined Source.
Iwata T; Honma K; Hanano H; Kadokura A; Nagata E; Takizawa S
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):251-255. PubMed ID: 30529219
[TBL] [Abstract][Full Text] [Related]
3. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J
Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284
[TBL] [Abstract][Full Text] [Related]
4. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation.
Matsumoto M; Sakaguchi M; Okazaki S; Furukado S; Tagaya M; Etani H; Shimazu T; Yoshimine T; Mochizuki H; Kitagawa K
Cerebrovasc Dis; 2013; 35(1):64-72. PubMed ID: 23428999
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of Trousseau's syndrome with multiple acute ischemic strokes.
Ling Y; Li Y; Zhang X; Dong L; Wang J
Neurol Sci; 2022 Apr; 43(4):2405-2411. PubMed ID: 34564800
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke.
Alvarez-Perez FJ; Castelo-Branco M; Alvarez-Sabin J
J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):986-92. PubMed ID: 21296900
[TBL] [Abstract][Full Text] [Related]
7. Ability of the number of territories involved on DWI-MRI to predict occult systemic malignancy in cryptogenic stroke patients.
Guo L; Wang L; Liu W
J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104823. PubMed ID: 32362555
[TBL] [Abstract][Full Text] [Related]
8. The relationship between anemia and recurrence of ischemic stroke in patients with Trousseau's syndrome: A retrospective cross-sectional study.
Yigit M; Sogut O; Yigit E; Turkdogan KA; Kaplan O; Dur A; Sonmez E; Demirel B
Turk J Emerg Med; 2016 Jun; 16(2):65-68. PubMed ID: 27896324
[TBL] [Abstract][Full Text] [Related]
9. Cerebral Infarction Caused by Trousseau's Syndrome Associated With Lung Cancer.
Ikuta S; Nishimatsu K; Shoshihara N; Masuhiro K; Minami S
World J Oncol; 2022 Dec; 13(6):403-408. PubMed ID: 36660207
[TBL] [Abstract][Full Text] [Related]
10. Trousseau Syndrome Related Cerebral Infarction: Clinical Manifestations, Laboratory Findings and Radiological Features.
Bao L; Zhang S; Gong X; Cui G
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104891. PubMed ID: 32807409
[TBL] [Abstract][Full Text] [Related]
11. Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke.
Yamaguchi I; Kanematsu Y; Shimada K; Korai M; Miyamoto T; Shikata E; Yamaguchi T; Yamamoto N; Yamamoto Y; Kitazato KT; Okayama Y; Takagi Y
Cerebrovasc Dis Extra; 2019; 9(3):129-138. PubMed ID: 31760390
[TBL] [Abstract][Full Text] [Related]
12. D-dimer and Body CT to Identify Occult Malignancy in Acute Ischemic Stroke.
Rosenberg J; Do D; Cucchiara B; Messé SR
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105366. PubMed ID: 33039769
[TBL] [Abstract][Full Text] [Related]
13. Multifocal cerebral infarction as the first manifestation of occult malignancy: Case series of trousseau's syndrome and literature review.
Chen W; He Y; Su Y
Brain Circ; 2018; 4(2):65-72. PubMed ID: 30276339
[TBL] [Abstract][Full Text] [Related]
14. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD
Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943
[TBL] [Abstract][Full Text] [Related]
15. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.
Di Napoli M; Papa F;
Stroke; 2002 Jul; 33(7):1763-71. PubMed ID: 12105349
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mediators and cerebral embolism in carotid stenting: new markers of risk.
Pini R; Faggioli G; Fittipaldi S; Pasquinelli G; Tonon C; Beltrandi E; Mauro R; Stella A
J Endovasc Ther; 2013 Oct; 20(5):684-94. PubMed ID: 24093322
[TBL] [Abstract][Full Text] [Related]
17. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH
Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249
[TBL] [Abstract][Full Text] [Related]
18. Trousseau's Syndrome with Advanced Neuroendocrine Carcinoma of Colon: A Case Report.
Ohmura H; Tobo T; Mimori K; Baba E; Horiuchi T
Case Rep Oncol; 2023; 16(1):484-490. PubMed ID: 37497422
[TBL] [Abstract][Full Text] [Related]
19. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke.
Gon Y; Sakaguchi M; Takasugi J; Kawano T; Kanki H; Watanabe A; Oyama N; Terasaki Y; Sasaki T; Mochizuki H
Eur J Neurol; 2017 Mar; 24(3):503-508. PubMed ID: 28026909
[TBL] [Abstract][Full Text] [Related]
20. Clues to occult cancer in patients with ischemic stroke.
Kim SJ; Park JH; Lee MJ; Park YG; Ahn MJ; Bang OY
PLoS One; 2012; 7(9):e44959. PubMed ID: 22984594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
